Saturday, March 19, 2022 2:48:35 PM
Dallas, Texas, March 17, 2022 (GLOBE NEWSWIRE) -- Puration, Inc. (OTC Pink: PURA) and PAO Group, Inc. (OTC Pink: PAOG) are working together on a new line of CBD Nutraceuticals under PURA’s Farmersville Hemp Brand Name for the $40 billion women’s health market.
PURA and PAOG anticipate the new Farmersville Brand CBD Nutraceutical Line to boost 2022 revenue potentially beyond current projections.
PAOG revealed in a February strategic update that the two companies were working together on a new line of CBD Nutraceuticals under PURA’s Farmersville Hemp Brand Name. The joint CBD Nutraceutical developments have progressed, and the two companies now plan to launch the new product line next month in April.
The new CBD Nutraceuticals will be available on North American Cannabis Holding, Inc.’s (OTC Pink: USMJ) ecommerce site www.USMJ.com.
Look for more news coming soon on the several products that PURA and PAOG will introduced for the women’s health market under the Farmersville Brand name.
Read PURA’s latest comprehensive update on PURA’s Farmersville Hemp Brand rollout.
For more information on Puration, visit http://www.purationinc.com
Learn more about PAOG at www.paogroupinc.com.
Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.
For More Information Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
PAO Group, inc.
Jim DiPrima
888-272-6472
info@pao.group
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM